“…During the peak of equine clinical cytogenetics in the 1970s–1990s, many abnormal karyotypes were published and in the following years, and the findings have been well-reviewed in books [ 1 , 2 ], book chapters [ 3 , 4 , 5 , 6 , 7 ], and multiple review papers, some specifically focusing on equine cytogenetics [ 8 , 9 , 10 ], others on cytogenetics of domestic animals, including the horse [ 11 , 12 , 13 , 14 ]. Since the last comprehensive and horse-focused reviews about a decade ago [ 4 , 5 ], equine clinical cytogenetics has advanced qualitatively, mainly thanks to the progress in equine genomics and the availability of new powerful genomic tools (reviewed by [ 15 ]).…”